Updated 1 November 2005

1. Canadian Cancer Society/National Cancer Institute of Canada: Canadian Cancer Statistics 2005, Toronto, Canada, 2005.
2. Lowenfels AB, Maisonneuve P. Risk factors for pancreatic cancer.  J Cell Biochem 2005;95:649-56.
3. Yeo TP, Hruban RH, Leach SD, et al.  Pancreatic cancer. Curr Probl Cancer 2002;26:176-275.
4. Cowgill SM, Muscarella P.  The genetics of pancreatic cancer. Am J Surg 2003;186:279-86.
5. Hruban RH, Petersen GM, Ha PK, et al.  Genetics of pancreatic cancer: from genes to families. Surg Oncol Clin N Am 1998;7:1-23.
6. Abrams RA, Grochow LB, Chakravarthy A, et al. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Int J Radiat Oncol Biol Phys 1999;44:1039-46.
7. Legmann P, Vignaux O, Dousset B, et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998;170:1315-22.
8. Fernandez-del Castillo C, Warshaw AL. Laparoscopic staging and peritoneal cytology. Surg Oncol Clin N Am 1998;7:135-42.
9. Adsay NV, Longnecker DS, Klimstra DS. Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms. Semin Diagn Pathol 2000;17:16-30.
10. Compton CC. Serous cystic tumors of the pancreas. Semin Diagn Pathol 2000:17:43-55.
11. Abraham SC, Klimstra DS, Wilentz RE, et al. Solid-pseudopapillary tumors of the pancreas almost always harbor mutations in the beta-catenin gene. Am J Pathol 2002;160: 1361-9.
12. Kalser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899-903.
13. Klinkenbijl JH, Jeekel J, Sahmoud T, et al.: Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776-82.
14. Neoptolemos JP, Dunn JA, Stocken DD, et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomized controlled trial. Lancet 2001;358:1576-85.
15. Evans DB. Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas. J Gastrointest Surg 2001;5:2-5.
16. Willett CG, Czito BG, Bendell JC, Ryan DP. Locally advanced pancreatic cancer. J Clin Oncol 2005 Jul 10;23:4538-44.
17. Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403-13.
18. Moore MJ, Goldstein D, Hamm J, et al.  Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer. A phase III trial of the National Cancer Institute of Canada Clinical Trials Group [NCIC-CTG] 2005 Proc Am Soc Clin Oncol 2005, abstr 1.